{"id":"aa","safety":{"commonSideEffects":[{"rate":"30-50%","effect":"Fatigue"},{"rate":"20-40%","effect":"Nausea"},{"rate":"10-30%","effect":"Diarrhea"}]},"_chembl":null,"_dailymed":{"setId":"853130e5-7406-4fd6-8138-ff2179195927","title":"OTULFI (USTEKINUMAB-AAUZ) INJECTION, SOLUTION OTULFI (USTEKINUMAB-AAUZ) SOLUTION [FRESENIUS KABI USA, LLC]"},"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Radiation therapy works by damaging the DNA of cancer cells, which prevents them from growing and dividing. This can be achieved through external beam radiation therapy, where a machine directs radiation beams at the tumor, or through internal radiation therapy, where a small amount of radioactive material is placed inside the body near the tumor.","oneSentence":"Radiation therapy is a treatment that uses high doses of radiation to kill cancer cells.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:58:30.509Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Cancer treatment"}]},"trialDetails":[{"nctId":"NCT03686124","phase":"PHASE1, PHASE2","title":"ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors","status":"RECRUITING","sponsor":"Immatics US, Inc.","startDate":"2019-05-14","conditions":"Refractory Cancer, Recurrent Cancer, Solid Tumor, Adult","enrollment":375},{"nctId":"NCT03374215","phase":"","title":"Clinical and Molecular Characteristics of Primary Aldosteronism in Blacks","status":"RECRUITING","sponsor":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","startDate":"2017-12-14","conditions":"Adrenal Gland Neoplasm, Hypertension, Bone Diseases, Metabolic","enrollment":1150},{"nctId":"NCT03431350","phase":"PHASE2","title":"A Study of Niraparib Combination Therapies for the Treatment of Metastatic Castration-Resistant Prostate Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Janssen Research & Development, LLC","startDate":"2018-03-02","conditions":"Prostatic Neoplasms, Castration-Resistant","enrollment":136},{"nctId":"NCT06421935","phase":"PHASE1","title":"M9466 Alone or in Combination in Advanced Solid Tumors (DDriver 501)","status":"ACTIVE_NOT_RECRUITING","sponsor":"EMD Serono Research & Development Institute, Inc.","startDate":"2024-08-07","conditions":"Advanced Solid Tumor","enrollment":141},{"nctId":"NCT05020106","phase":"","title":"The Diagnostic Cut-off Value of Core Biomarkers of Alzheimer's Disease","status":"RECRUITING","sponsor":"Capital Medical University","startDate":"2018-09-01","conditions":"Alzheimer's Disease","enrollment":3200},{"nctId":"NCT04850053","phase":"","title":"Detection of Alzheimer's Disease (AD)-Related Seeds for AD Diagnosis","status":"RECRUITING","sponsor":"Capital Medical University","startDate":"2020-08-26","conditions":"Alzheimer's Disease","enrollment":1500},{"nctId":"NCT04575337","phase":"","title":"Study on Biomarkers for Early Diagnosis of Alzheimer's Disease","status":"RECRUITING","sponsor":"Capital Medical University","startDate":"2020-05-28","conditions":"Alzheimer Disease","enrollment":6000},{"nctId":"NCT04497844","phase":"PHASE3","title":"A Study of Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for the Treatment of Participants With Deleterious Germline or Somatic Homologous Recombination Repair (HRR) Gene-Mutated Metastatic Castration-Sensitive Prostate Cancer (mCSPC)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Janssen Research & Development, LLC","startDate":"2020-09-23","conditions":"Metastatic Castration-sensitive Prostate Cancer","enrollment":696},{"nctId":"NCT05224557","phase":"","title":"Analysis of Cardiac Biomarker Racial Discrepancies","status":"ENROLLING_BY_INVITATION","sponsor":"Methodist Health System","startDate":"2021-09-15","conditions":"Heart Failure","enrollment":400},{"nctId":"NCT02405676","phase":"PHASE2, PHASE3","title":"BNHL-2015 for Children or Adolescents in China","status":"ACTIVE_NOT_RECRUITING","sponsor":"Children's Cancer Group, China","startDate":"2015-01-01","conditions":"Mature B-cell Non-Hodgkin Lymphoma","enrollment":200},{"nctId":"NCT02257736","phase":"PHASE3","title":"An Efficacy and Safety Study of Apalutamide (JNJ-56021927) in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone in Participants With Chemotherapy-naive Metastatic Castration-resistant Prostate Cancer (mCRPC)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Aragon Pharmaceuticals, Inc.","startDate":"2014-11-26","conditions":"Prostatic Neoplasms","enrollment":982},{"nctId":"NCT05293756","phase":"NA","title":"OPtimizing Technology to Improve Medication Adherence and BP Control (OPTIMA-BP)","status":"RECRUITING","sponsor":"Case Western Reserve University","startDate":"2021-02-14","conditions":"Hypertension, Self-Management, Technology","enrollment":208},{"nctId":"NCT03748641","phase":"PHASE3","title":"A Study of Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for Treatment of Participants With Metastatic Prostate Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Janssen Research & Development, LLC","startDate":"2019-01-25","conditions":"Castration-Resistant Prostatic Cancer","enrollment":765},{"nctId":"NCT07178210","phase":"NA","title":"Robotic-Enabled Microsurgical Intervention for Neurodegenerative Disease","status":"RECRUITING","sponsor":"MMI (Medical Microinstruments, Inc.)","startDate":"2026-03-31","conditions":"Alzheimer Disease, Lymphatic Obstruction","enrollment":15},{"nctId":"NCT02123758","phase":"PHASE1","title":"A Study of JNJ-56021927 (ARN-509) and Abiraterone Acetate in Participants With Metastatic Castration-Resistant Prostate Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Aragon Pharmaceuticals, Inc.","startDate":"2014-07-09","conditions":"Prostatic Neoplasms, Metastatic Castration-Resistant Prostate Cancer","enrollment":57},{"nctId":"NCT04577833","phase":"PHASE1","title":"A Study of Comparative Formulations of Niraparib and Abiraterone Acetate (AA) in Men With Prostate Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Janssen Research & Development, LLC","startDate":"2020-11-13","conditions":"Prostatic Neoplasms","enrollment":136},{"nctId":"NCT06395467","phase":"NA","title":"Integrated Treatment for Enhancing Growth in Recovery During Adolescence","status":"RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2024-11-26","conditions":"Alcohol Use Disorder, Cannabis Use Disorder","enrollment":294},{"nctId":"NCT05045066","phase":"EARLY_PHASE1","title":"Immunological Effects of Vitamin D Replacement Among Black/African American Prostate Cancer Patients","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2021-12-29","conditions":"Localized Prostate Carcinoma, Stage IV Prostate Cancer AJCC v8, Locally Recurrent Prostate Carcinoma","enrollment":220},{"nctId":"NCT06975241","phase":"PHASE4","title":"Observing Metabolism of EPA With Consideration of Genetics And Sex","status":"RECRUITING","sponsor":"University of Toronto","startDate":"2025-07-29","conditions":"Healthy, Omega 3, Metabolism, Lipids","enrollment":64},{"nctId":"NCT06650579","phase":"PHASE3","title":"REVELUTION-2: Relugolix+Abiraterone Acetate (AA) Versus Leuprolide+AA Cardiac Trial","status":"RECRUITING","sponsor":"Emory University","startDate":"2025-01-31","conditions":"Recurrent Prostate Carcinoma, Stage III Prostate Cancer AJCC v8, Stage IVA Prostate Cancer AJCC v8","enrollment":72},{"nctId":"NCT05487378","phase":"NA","title":"Evaluation of Phe Fluctuation in PKU Pts Treated With PKU GOLIKE Versus Standard Amino Acid Protein Substitute.","status":"COMPLETED","sponsor":"APR Applied Pharma Research s.a.","startDate":"2023-06-30","conditions":"Phenylketonurias","enrollment":16},{"nctId":"NCT05849753","phase":"","title":"Breaking Disparities in Access to Advanced Diabetes Technologies in Children With Type 1 Diabetes","status":"RECRUITING","sponsor":"Nemours Children's Clinic","startDate":"2023-07-26","conditions":"Diabetes Mellitus, Type 1, Child, Delivery of Health Care","enrollment":50},{"nctId":"NCT01105169","phase":"NA","title":"Precision-Based Magnesium Trial","status":"COMPLETED","sponsor":"Vanderbilt University Medical Center","startDate":"2011-03-11","conditions":"Colorectal Cancer","enrollment":250},{"nctId":"NCT06531109","phase":"","title":"Characterization And Clinical Outcomes of AA Patients Treated With Ritlecitinib","status":"RECRUITING","sponsor":"Pfizer","startDate":"2024-08-07","conditions":"Alopecia Areata","enrollment":850},{"nctId":"NCT06686446","phase":"NA","title":"Allergic Rhinitis Improvement Through Strategic Education: The ARISE Trial","status":"TERMINATED","sponsor":"Murdoch Childrens Research Institute","startDate":"2025-08-22","conditions":"Allergy","enrollment":18},{"nctId":"NCT06287268","phase":"","title":"Revolade Tablets Specified Drug-use Survey","status":"RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2024-07-17","conditions":"Aplastic Anemia","enrollment":10},{"nctId":"NCT05419128","phase":"NA","title":"Family-focused vs. Drinker-focused Smartphone Interventions to Reduce Drinking-related Consequences of COVID-19","status":"COMPLETED","sponsor":"University of Wisconsin, Madison","startDate":"2022-04-06","conditions":"Alcohol Use Disorder, Family Members, Behavior, Addictive","enrollment":398},{"nctId":"NCT05995717","phase":"NA","title":"Evaluation of PKU UP","status":"ACTIVE_NOT_RECRUITING","sponsor":"Vitaflo International, Ltd","startDate":"2024-01-11","conditions":"PKU","enrollment":16},{"nctId":"NCT03507257","phase":"","title":"Longitudinal Early-onset Alzheimer's Disease Study Protocol","status":"RECRUITING","sponsor":"Indiana University","startDate":"2018-04-30","conditions":"Early Onset Alzheimer Disease, Alzheimer Disease, Mild Cognitive Impairment","enrollment":850},{"nctId":"NCT03206060","phase":"PHASE2","title":"Lu-177-DOTATATE (Lutathera) in Therapy of Inoperable Pheochromocytoma/ Paraganglioma","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2017-10-10","conditions":"Pheochromocytoma, Paraganglioma, Neuroendocrine Tumors","enrollment":130},{"nctId":"NCT07410663","phase":"","title":"Hyaluronic Acid and Amino Acid Combination Versus Exercise for Chronic Lateral Epicondylitis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Sivas State Hospital","startDate":"2025-12-01","conditions":"Lateral Epicondylitis","enrollment":60},{"nctId":"NCT07226531","phase":"","title":"Utilization and Effectiveness of Ritlecitinib in a Real-World Population With Severe AA in the US","status":"NOT_YET_RECRUITING","sponsor":"Pfizer","startDate":"2026-02-16","conditions":"Alopecia Areata","enrollment":300},{"nctId":"NCT07406204","phase":"PHASE4","title":"Tofacitinib vs Methotrexate for Severe Alopecia Areata (TOFA-MTX-AA)","status":"NOT_YET_RECRUITING","sponsor":"Hayat Abad Medical Complex, Peshawar","startDate":"2026-02-15","conditions":"Alopecia Areata, Alopecia Totalis (AT), Alopecia Universalis","enrollment":78},{"nctId":"NCT04197934","phase":"PHASE1","title":"WSD0922-FU for the Treatment of Glioblastoma, Anaplastic Astrocytoma, or Non-small Cell Lung Cancer With Central Nervous System Metastases","status":"ACTIVE_NOT_RECRUITING","sponsor":"Mayo Clinic","startDate":"2019-12-20","conditions":"Anaplastic Astrocytoma, IDH-Wildtype, Glioblastoma, IDH-Wildtype, Metastatic Lung Non-Small Cell Carcinoma","enrollment":56},{"nctId":"NCT07400341","phase":"PHASE2","title":"Romiplostim Versus rhTPO for Platelet Engraftment After Transplant in MDS and AA","status":"NOT_YET_RECRUITING","sponsor":"The First Affiliated Hospital of Soochow University","startDate":"2026-01-31","conditions":"MDS (Myelodysplastic Syndrome), Aplastic Anemia (AA)","enrollment":66},{"nctId":"NCT06562270","phase":"","title":"CorEvitas International Adolescent Alopecia Areata (AA) Drug Safety and Effectiveness Registry","status":"RECRUITING","sponsor":"CorEvitas","startDate":"2024-03-07","conditions":"Alopecia Areata","enrollment":1500},{"nctId":"NCT05745389","phase":"","title":"CorEvitas Alopecia Areata (AA) Safety and Effectiveness Registry","status":"RECRUITING","sponsor":"CorEvitas","startDate":"2022-10-25","conditions":"Alopecia Areata","enrollment":5000},{"nctId":"NCT01358747","phase":"PHASE3","title":"Study of a Treatment Driven by Early PET Response to a Treatment Not Monitored by Early PET in Patients With AA Stage 3-4 or 2B HL","status":"COMPLETED","sponsor":"Centre Hospitalier Universitaire Dijon","startDate":"2011-05","conditions":"Hodgkin's Lymphoma","enrollment":""},{"nctId":"NCT05478239","phase":"PHASE2","title":"ArtemiCoffee in Patients With Rising PSA","status":"ACTIVE_NOT_RECRUITING","sponsor":"Zin W Myint","startDate":"2023-08-11","conditions":"Prostate Cancer","enrollment":20},{"nctId":"NCT07242638","phase":"PHASE2","title":"Treatment of Atopic Dermatitis and Alopecia Areata With Abrocitinib in Individuals With Down Syndrome","status":"RECRUITING","sponsor":"Icahn School of Medicine at Mount Sinai","startDate":"2026-01-12","conditions":"Atopic Dermatitis, Alopecia Areata","enrollment":56},{"nctId":"NCT06821061","phase":"PHASE1, PHASE2","title":"A Study to Learn About How the Flu and COVID-19 Vaccines Act in Healthy People","status":"COMPLETED","sponsor":"BioNTech SE","startDate":"2025-02-10","conditions":"Influenza, COVID-19 (Coronavirus Disease 2019)","enrollment":2650},{"nctId":"NCT03370393","phase":"NA","title":"Prevention of Adolescent Risky Behaviors: Neural Markers of Intervention Effects","status":"COMPLETED","sponsor":"University of California, Irvine","startDate":"2017-12-11","conditions":"Risk-Taking, Adolescent Behavior","enrollment":146},{"nctId":"NCT06327581","phase":"NA","title":"Combined Microneedling With Either 1% Lactic Acid Solution or Vitamin D3 or Triamcinolone Acetonide in The Treatment of Alopecia Areata","status":"RECRUITING","sponsor":"Zagazig University","startDate":"2023-12-15","conditions":"Alopecia Areata","enrollment":88},{"nctId":"NCT04756063","phase":"PHASE4","title":"Parenteral Ascorbic Acid Repletion in TransplantatIon","status":"SUSPENDED","sponsor":"University of Wisconsin, Madison","startDate":"2026-03","conditions":"Liver Transplant Failure and Rejection","enrollment":90},{"nctId":"NCT01008787","phase":"NA","title":"Motivational Interviewing for Physical Activity","status":"ACTIVE_NOT_RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2009-07-28","conditions":"Cancer","enrollment":80},{"nctId":"NCT07328087","phase":"EARLY_PHASE1","title":"COLONYVAQ™, a Quantum-Classical Guided Personalized Neoantigen Vaccine for MSS Stage III Colorectal Cancer","status":"RECRUITING","sponsor":"Biogenea Pharmaceuticals Ltd.","startDate":"2026-02-02","conditions":"Colorectal Cancer Metastatic, Colorectal Cancer Stage III, Colorectal Cancer Stage IV","enrollment":12},{"nctId":"NCT06510777","phase":"NA","title":"PICO Venous Leg Ulcers (VLU) Reimbursement Study","status":"TERMINATED","sponsor":"Smith & Nephew, Inc.","startDate":"2023-12-29","conditions":"Venous Insufficiency, Venous Leg Ulcer","enrollment":142},{"nctId":"NCT06001320","phase":"PHASE3","title":"De-novo Initiation of Letermovir vs Valganciclovir for Cytomegalovirus Prophylaxis in AA Kidney Transplant Recipients","status":"ACTIVE_NOT_RECRUITING","sponsor":"Virginia Commonwealth University","startDate":"2023-09-25","conditions":"Kidney Transplant; Complications, CMV","enrollment":60},{"nctId":"NCT07321548","phase":"","title":"Investigating the Gut Microbiota of Individuals With Adenoma, Advanced Adenoma and Colorectal Cancer","status":"COMPLETED","sponsor":"Chinese University of Hong Kong","startDate":"2021-03-15","conditions":"Colorectal Cancer, Colorectal Adenoma, Colorectal Neoplasms","enrollment":1757},{"nctId":"NCT07322601","phase":"NA","title":"Supportive Analgesic Effect of Auricular Acupressure (AA) After Cesarean Section (CS)","status":"COMPLETED","sponsor":"University of Medicine and Pharmacy at Ho Chi Minh City","startDate":"2024-10-14","conditions":"Pain Postoperative, Caesarean Section; Pain","enrollment":70},{"nctId":"NCT07319793","phase":"NA","title":"Pre-DLI or Pro-DLI in Relapsed/Refractory Myeloid Neoplasms After HSCT","status":"NOT_YET_RECRUITING","sponsor":"Peking University People's Hospital","startDate":"2026-01-01","conditions":"Acute Myeloid Leukemia, Myelodysplastic Syndromes (MDS)","enrollment":200},{"nctId":"NCT07288008","phase":"NA","title":"Transcranial Alternating Current Stimulation (tACS) for the Treatment of Anxiety in Veterans: An Open-Label Pilot Study","status":"RECRUITING","sponsor":"Birmingham VA Health Care System","startDate":"2025-12-15","conditions":"Anxiety","enrollment":40},{"nctId":"NCT07309588","phase":"PHASE1, PHASE2","title":"Hyaluronic Acid in the Treatment of Hyposalivation","status":"ENROLLING_BY_INVITATION","sponsor":"Poznan University of Medical Sciences","startDate":"2025-07-01","conditions":"Xerostomia Due to Hyposecretion of Salivary Gland","enrollment":100},{"nctId":"NCT06340360","phase":"PHASE2","title":"A Phase 2b Study to Evaluate Rezpegaldesleukin (Rezpeg) in the Treatment of Severe to Very Severe Alopecia Areata in Adult Patients (Rezolve AA)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Nektar Therapeutics","startDate":"2024-04-02","conditions":"Alopecia Areata","enrollment":94},{"nctId":"NCT05012618","phase":"PHASE1","title":"A Dose-escalation Study of LUNA18 in Patients With Locally Advanced or Metastatic Solid Tumors (With Expansion).","status":"TERMINATED","sponsor":"Chugai Pharmaceutical","startDate":"2021-10-08","conditions":"Locally Advanced or Metastatic Solid Tumors","enrollment":128},{"nctId":"NCT07023302","phase":"PHASE3","title":"A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants in Japan With Alopecia Areata","status":"RECRUITING","sponsor":"AbbVie","startDate":"2025-06-19","conditions":"Alopecia Areata","enrollment":123},{"nctId":"NCT06074341","phase":"NA","title":"TeleHealth Resources for IndiVidualizEd Goals (THRIVE) in Alcohol Recovery Study","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of New Mexico","startDate":"2023-09-13","conditions":"Alcohol Use Disorder, Alcohol Drinking, Alcohol-Related Disorders","enrollment":470},{"nctId":"NCT07284602","phase":"PHASE3","title":"Trial to Evaluate the Efficacy and Safety of LYT-100 (Deupirfenidone) Compared to Pirfenidone in Adults With Idiopathic Pulmonary Fibrosis (IPF)","status":"NOT_YET_RECRUITING","sponsor":"PureTech","startDate":"2026-04","conditions":"Idiopathic Pulmonary Fibrosis (IPF)","enrollment":1100},{"nctId":"NCT07150806","phase":"PHASE1, PHASE2","title":"RYZ101 for the Treatment of Progressive or Recurrent Intracranial Meningioma","status":"RECRUITING","sponsor":"Joshua Palmer","startDate":"2025-11-12","conditions":"Recurrent Meningioma","enrollment":30},{"nctId":"NCT07269938","phase":"","title":"Mapping B-cell Biology Across the Cardiovascular Territories of Giant Cell Arteritis: Towards a New Therapeutic Approach (RituxiMAP GCA)","status":"NOT_YET_RECRUITING","sponsor":"University of Edinburgh","startDate":"2026-04","conditions":"Giant Cell Arteritis (GCA)","enrollment":30},{"nctId":"NCT04086485","phase":"PHASE1, PHASE2","title":"Lu-177-DOTATATE (Lutathera) in Combination With Olaparib in Inoperable Gastroenteropancreatico Neuroendocrine Tumors (GEP-NET)","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2022-10-03","conditions":"Gastroenteropancreatico Tumors, Neuroendocrine Tumors, Neuroendocrine Neoplasms","enrollment":56},{"nctId":"NCT05161663","phase":"NA","title":"Peer-driven Intervention on PrEP","status":"COMPLETED","sponsor":"The Miriam Hospital","startDate":"2022-01-06","conditions":"HIV Infections","enrollment":98},{"nctId":"NCT07287228","phase":"PHASE1, PHASE2","title":"The Safety and Efficacy of Daratumumab in Patients With Refractory Aplastic Anemia","status":"NOT_YET_RECRUITING","sponsor":"Institute of Hematology & Blood Diseases Hospital, China","startDate":"2025-12-10","conditions":"Aplastic Anemia, Refractory, Relapse","enrollment":37},{"nctId":"NCT07279818","phase":"NA","title":"Improving Chemotherapy Induced Peripheral Neuropathy in Children With Leukemia: A Study of Transcutaneous Acupoints Electrical Stimulation and Auricular Acupressure Interventions","status":"NOT_YET_RECRUITING","sponsor":"The Hong Kong Polytechnic University","startDate":"2025-12-08","conditions":"Chemotherapy Induced Peripheral Neuropathy (CIPN)","enrollment":132},{"nctId":"NCT06602232","phase":"PHASE1","title":"A Study of DR-01 in Subjects With Alopecia Areata and Vitiligo","status":"RECRUITING","sponsor":"Dren Bio","startDate":"2024-10-30","conditions":"Alopecia Areata, Vitiligo","enrollment":80},{"nctId":"NCT06023446","phase":"","title":"Can (Optical Coherence Tomography) Pictures of the Retina Detect Alzheimer's Disease at Its Earliest Stages?","status":"ENROLLING_BY_INVITATION","sponsor":"University of California, Davis","startDate":"2023-09-29","conditions":"Alzheimer Disease, Mild Cognitive Impairment","enrollment":100},{"nctId":"NCT05398809","phase":"PHASE2","title":"Evaluate the Efficacy and Safety of Ruxolitinib on Hair Regrowth in Patients With Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy (APECED)-Associated Alopecia Areata","status":"RECRUITING","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2023-01-18","conditions":"Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy (Apeced), Alopecia Areata","enrollment":70},{"nctId":"NCT03225677","phase":"","title":"Novel Tracer Methods to Evaluate Muscle Protein Metabolism in Cirrhosis","status":"RECRUITING","sponsor":"The Cleveland Clinic","startDate":"2017-08-03","conditions":"Cirrhosis","enrollment":20},{"nctId":"NCT06762275","phase":"NA","title":"The Impact of a Diagnostic Strategy for Acute Appendicitis in Children With Acute Abdominal Pain in Primary Care","status":"RECRUITING","sponsor":"University Medical Center Groningen","startDate":"2025-03-06","conditions":"Appendicitis Acute, Acute Abdomen in Children","enrollment":566},{"nctId":"NCT03525002","phase":"PHASE2","title":"Dopamine Action on Metabolism in Relation to Genotype","status":"COMPLETED","sponsor":"University Hospital Tuebingen","startDate":"2018-05-03","conditions":"Obesity","enrollment":120},{"nctId":"NCT07245251","phase":"NA","title":"To Evaluate the Safety, Tolerability, and Preliminary Antitumor Activity of STR-P004","status":"NOT_YET_RECRUITING","sponsor":"Starna Therapeutics","startDate":"2025-12-03","conditions":"Acute Lymphobkastic Leukemia","enrollment":11},{"nctId":"NCT07237308","phase":"PHASE4","title":"BEACON-AA: Apixaban With or Without Clopidogrel in Stroke Patients With Atrial Fibrillation and Cerebral Atherosclerosis","status":"NOT_YET_RECRUITING","sponsor":"Yonsei University","startDate":"2025-12","conditions":"Stroke, Ischemic, Atrial Fibrillation","enrollment":586},{"nctId":"NCT05522556","phase":"","title":"Pre-approval Single-patient Expanded Access for Ritlecitinib (PF-06651600)","status":"AVAILABLE","sponsor":"Pfizer","startDate":"","conditions":"Alopecia Areata","enrollment":""},{"nctId":"NCT06018428","phase":"PHASE2","title":"A Phase 2a Proof-of-Concept Trial of Bempikibart (ADX-914) for the Treatment of Severe Alopecia Areata (SIGNAL-AA)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Q32 Bio Inc.","startDate":"2023-09-12","conditions":"Alopecia Areata","enrollment":75},{"nctId":"NCT06433622","phase":"","title":"Platelet Transfusion and Repeat TEG-PM in Patients With Severe TBI on Antiplatelet Therapy (Repeat TEG-PM)","status":"ENROLLING_BY_INVITATION","sponsor":"Lancaster General Hospital","startDate":"2023-12-01","conditions":"Traumatic Intracranial Hemorrhage","enrollment":225},{"nctId":"NCT04618653","phase":"","title":"Comprehensive Process Model of AA-related Behavior Change","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of New Mexico","startDate":"2020-09-28","conditions":"Alcohol Use Disorder (AUD)","enrollment":192},{"nctId":"NCT07176234","phase":"NA","title":"The LEADS Trial (Linking Exericise for Advancing Daily Stress Management)","status":"RECRUITING","sponsor":"University of South Carolina","startDate":"2025-01-25","conditions":"Obesity, Childhood","enrollment":330},{"nctId":"NCT07214610","phase":"NA","title":"Integrating Biological, Clinical, and Behavioral Factors to Improve Breast Cancer Outcomes - Carolina Breast Cancer Study","status":"RECRUITING","sponsor":"UNC Lineberger Comprehensive Cancer Center","startDate":"2023-11-28","conditions":"Breast Cancer, Breast Neoplasms","enrollment":3300},{"nctId":"NCT01624805","phase":"PHASE2","title":"Methylprednisolone, Horse Anti-Thymocyte Globulin, Cyclosporine, Filgrastim, and/or Pegfilgrastim or Pegfilgrastim Biosimilar in Treating Patients With Aplastic Anemia or Low or Intermediate-Risk Myelodysplastic Syndrome","status":"RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2012-06-25","conditions":"Aplastic Anemia, de Novo Myelodysplastic Syndrome, Myelodysplastic Syndrome","enrollment":140},{"nctId":"NCT06661564","phase":"NA","title":"Identification of Diagnosis Biomarkers in the Tears of Alzheimer's Disease Patients: The COG-EYE Pilot Study","status":"RECRUITING","sponsor":"University Hospital, Tours","startDate":"2025-07-09","conditions":"Alzheimer Disease","enrollment":90},{"nctId":"NCT00873951","phase":"NA","title":"Influence of Protein Hydrolysis on Dietary Protein Digestibility and Metabolism in Healthy Subjects","status":"COMPLETED","sponsor":"Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement","startDate":"2006-01","conditions":"Healthy","enrollment":26},{"nctId":"NCT05998031","phase":"NA","title":"A Mechanistic Study to Investigate tDCS and Working Memory in MCI Patients","status":"RECRUITING","sponsor":"University of Florida","startDate":"2024-04-24","conditions":"Cognitive Impairment, Cognitive Decline","enrollment":110},{"nctId":"NCT01172314","phase":"NA","title":"Effects of Essential Amino Acid Intake on Net Protein Synthesis in Weight-losing Non-small Cell Lung Cancer Patients","status":"COMPLETED","sponsor":"Texas A&M University","startDate":"2010-07-13","conditions":"Non-small Cell Lung Cancer","enrollment":41},{"nctId":"NCT01173354","phase":"NA","title":"EAA Intake to Optimize Protein Anabolism in COPD","status":"COMPLETED","sponsor":"Texas A&M University","startDate":"2009-09-08","conditions":"Chronic Obstructive Pulmonary Disease","enrollment":34},{"nctId":"NCT05615233","phase":"NA","title":"TACAD Program for Asian American Family Caregivers of Persons Living With Alzheimer's Disease","status":"COMPLETED","sponsor":"University of Texas at Austin","startDate":"2024-04-05","conditions":"Alzheimer Disease","enrollment":54},{"nctId":"NCT05004051","phase":"","title":"ViTAA Registry Pre- and Post-Operative Monitoring for Endovascular Aortic Aneurysm Repair and Serial Monitoring for AAA","status":"RECRUITING","sponsor":"ViTAA Medical Solutions","startDate":"2021-12-15","conditions":"Abdominal Aortic Aneurysms","enrollment":200},{"nctId":"NCT07183306","phase":"PHASE1, PHASE2","title":"A Clinical Study of HT-101 and/or HT-102 in Patients With Chronic Hepatitis B Virus Infection","status":"ACTIVE_NOT_RECRUITING","sponsor":"Suzhou HepaThera Biotech Co., Ltd.","startDate":"2024-12-30","conditions":"Chronic Hepatitis B","enrollment":86},{"nctId":"NCT00608764","phase":"","title":"Examining the Genetic Factors That May Cause Chronic Obstructive Pulmonary Disease (COPD)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Brigham and Women's Hospital","startDate":"2007-11","conditions":"Pulmonary Disease, Chronic Obstructive, Emphysema, Bronchitis, Chronic","enrollment":10718},{"nctId":"NCT07059234","phase":"NA","title":"The Motor Activity - Subjective Energy (MASE) Project","status":"RECRUITING","sponsor":"University of Bern","startDate":"2025-09-02","conditions":"Depressive Disorder, Major","enrollment":180},{"nctId":"NCT07174011","phase":"PHASE4","title":"Evaluation of the Efficacy and Safety of Oral Roflumilast Versus Intralesional Corticosteroids Injection (ILCs) in the Treatment of Alopecia Areata","status":"COMPLETED","sponsor":"Cairo University","startDate":"2025-01-12","conditions":"Alopecia, Alopecia Areata","enrollment":50},{"nctId":"NCT07168980","phase":"PHASE2, PHASE3","title":"Chemotherapy With Rituximab for Aggressive B-NHL in Children and Adolescents","status":"RECRUITING","sponsor":"Children's Cancer Group, China","startDate":"2025-07-01","conditions":"Mature B-cell Non-Hodgkin Lymphoma","enrollment":87},{"nctId":"NCT03109067","phase":"NA","title":"Genetic and Metabolism of Post-prandial HDL Particles","status":"COMPLETED","sponsor":"Institut National de la Santé Et de la Recherche Médicale, France","startDate":"2011-09-21","conditions":"Healthy Volunteers","enrollment":100},{"nctId":"NCT06354322","phase":"","title":"Unclassified GENotypes of Autoinflammatory Diseases and AA Amyloidosis","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2025-02-26","conditions":"AA Amyloidosis, Autoinflammatory Disease","enrollment":200},{"nctId":"NCT05714280","phase":"NA","title":"PA4Health Physical Activity App Open Pilot Study for African American Women","status":"ACTIVE_NOT_RECRUITING","sponsor":"City University of New York, School of Public Health","startDate":"2023-02-25","conditions":"Test Acceptability/Usability of a Physical Activity App Developed for African American Women","enrollment":15},{"nctId":"NCT07131111","phase":"","title":"Impact of Aortic Geometry on Vascular Remodeling After Stent Implantation in Coarctation of the Aorta","status":"NOT_YET_RECRUITING","sponsor":"Assiut University","startDate":"2025-09-01","conditions":"Aortic Geometry, Vascular Remodeling, Coarctation of Aorta","enrollment":50},{"nctId":"NCT07129889","phase":"NA","title":"Auricular Acupressure Reduces Rebound Effects After Discontinuation of Atropine","status":"NOT_YET_RECRUITING","sponsor":"Ningbo Eye Hospital","startDate":"2025-12-02","conditions":"Myopia","enrollment":180},{"nctId":"NCT06650553","phase":"NA","title":"Umbilical Cord Blood-Supported Haplo-HSCT for Aplastic Anemia Treatment Study","status":"RECRUITING","sponsor":"Shanxi Bethune Hospital","startDate":"2024-06-01","conditions":"Aplastic Anemias","enrollment":110},{"nctId":"NCT04871074","phase":"PHASE2","title":"The Synapse Project","status":"COMPLETED","sponsor":"University of Wisconsin, Madison","startDate":"2018-11-18","conditions":"Alzheimer Disease","enrollment":100},{"nctId":"NCT04958057","phase":"NA","title":"Social Risks-Focused Lifestyle Intervention to Reduce Preeclampsia (SAIL)","status":"COMPLETED","sponsor":"Medical College of Wisconsin","startDate":"2022-03-28","conditions":"Preeclampsia","enrollment":100},{"nctId":"NCT04515875","phase":"NA","title":"PRIMA Intervention for Adults With Mild Cognitive Impairment and Their Caregivers","status":"COMPLETED","sponsor":"Indiana University","startDate":"2021-12-13","conditions":"Mild Cognitive Impairment","enrollment":420}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":99122,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["flutamide","bicalutamide"],"phase":"marketed","status":"active","brandName":"AA","genericName":"AA","companyName":"Radiation Therapy Oncology Group","companyId":"radiation-therapy-oncology-group","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Radiation therapy is a treatment that uses high doses of radiation to kill cancer cells. Used for Cancer treatment.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}